Contact number
213 485 1234Provided by Chambers
Latham & Watkins LLP has a best-in-market corporate team with a sterling reputation for its counsel on M&A transactions, public and private securities offerings, and strategic partnerships. The team acts for early-stage and long-established companies as well as banks and financiers.
Latham & Watkins advised Merus in its $8 billion in its sale to Genmab.
Provided by Chambers
Latham's corporate experience is hard to match. It has encountered most, if not all, types of matters. If the partner you are working with hasn't seen it, all they have to do is inquire within.
The Latham team is a very knowledgeable group that act as a great partner to the company.
Latham & Watkins has deep expertise in M&A and provides creative solutions to deal challenges. The team also has excellent drafting and written work product.
The Latham & Watkins team has unrivalled expertise in providing strategic insight and effective solutions to complex legal situations.
The group is calm and patient and brings a breadth of experience to address the matter at hand.
Latham's corporate experience is hard to match. It has encountered most, if not all, types of matters. If the partner you are working with hasn't seen it, all they have to do is inquire within.
The Latham team is a very knowledgeable group that act as a great partner to the company.
Latham & Watkins has deep expertise in M&A and provides creative solutions to deal challenges. The team also has excellent drafting and written work product.
The Latham & Watkins team has unrivalled expertise in providing strategic insight and effective solutions to complex legal situations.
The group is calm and patient and brings a breadth of experience to address the matter at hand.
Provided by Chambers
Cheston Larson maintains a corporate and financing focus, frequently advising investment banks and venture capital firms along with public and private companies.
Charles always has insightful approaches.
Charles is a master in the boardroom. He is good at negotiating with counterparties and managing a set of directors with diverse sets of concerns.
Kate Hillier has a respected practice advising life sciences companies on licensing and collaborations, acquisitions and capital markets transactions. She regularly represents pharmaceutical and biotechnology companies nationally and internationally.
Kate is a licensing guru in the life sciences indsutry.
Kate is top-notch. She is incredibly invested and responsive, and can work efficiently, cutting through a lot of noise.
Kate has a wealth of understanding and the unique ability to understand both the scientific and corporate elements of the work.